Unfortunately, it has been histologically and transcriptionally shown that dysfunction of BRCA1 is common in TNBC 43, and more than 80% of breast cancers in women who carry germ-line BRCA1 mutations are triple-negative 44. This evidence concerns the gene BRCA1 and breast carcinoma.